
|Articles|August 15, 2005
Essilor acquires J&J ophthalmic lens business
Dallas—Essilor will acquire Johnson & Johnson Vision Care Inc.'s Spectacle Lens Group, including the group's Definity brand of progressive lenses.
Advertisement
Dallas-Essilor will acquire Johnson & Johnson Vision Care Inc.'s Spectacle Lens Group, including the group's Definity brand of progressive lenses.
The group is Johnson & Johnson Vision Care Inc.'s ophthalmic lens business. Terms of the deal, announced June 8, were not disclosed.
The Definity progressive lenses, introduced to U.S. test markets in late 2002, feature "Dual Add" technology that divides progressive add power between the front and back surfaces. Essilor will continue to manufacture the lenses and distribute them through its marketing and distribution networks.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
Oculis phase 3 DIAMOND trials miss vision endpoints in diabetic macular edema
2
Closing the gap: John Berdahl, MD, on the global cataract burden and the emerging dementia connection
3
FDA guidance to help accelerate cell and gene therapies
4
TearSolutions advances Lacripep into phase 2 following dual FDA designations in neurotrophic keratitis
5





















